After a breast-cancer diagnosis and a separate scare, my mom tested for the BRCA2 gene mutation. Knowing it could be hereditary, I decided to get tested at 23 to see if I also carried the mutation. My ...
Hosted on MSN
BRCA testing: Who needs it and how it's done
BRCA testing helps determine if you have a gene mutation that increases your cancer risk. People with a family history of certain cancers may consider BRCA testing. A positive BRCA result does not ...
A guide to finding out your breast cancer risk, and whether you should be tested for BRCA mutations. I like my boobs. They’re great. They look fine in a T-shirt, it feels good when they're touched, ...
In May 2013, nearly 20 years after the discovery that mutations on the BRCA1 and BRCA2 genes could lead to a higher risk of breast and ovarian cancer, A-list Hollywood actress Angelina Jolie garnered ...
BRCA1 and BRCA2 gene mutations increase the risk of hereditary breast cancer. Here's what you should know about the causes, genetic testing options, and prevention strategies to manage your cancer ...
A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.
Please provide your email address to receive an email when new articles are posted on . BRCA testing guidelines rely on age and the types, aggressiveness and quantity of cancers in a family, but ...
BRCA1 and BRCA2 are "tumor suppressor genes," meaning that, when normal, they make proteins that keep cells from growing abnormally, according to Cancer.org. "The way I explain it to patients is, they ...
Genetics is always changing. It seems as if every day there is a new article about a new study, and trying to navigate all of this information can be quite confusing. This past month, a new study was ...
Gila Pfeffer is a humor writer who splits her time between NYC and London. The following is an adapted excerpt from her memoir, "Nearly Departed: Adventures in Loss, Cancer, and Other Inconveniences." ...
Timely next-generation sequencing testing in patients with metastatic prostate cancer: A comparative analysis between Medicare Advantage and traditional Medicare. This is an ASCO Meeting Abstract from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results